Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. The company also provides Co-60 and gamma irradiators, which are principal components to the gamma sterilization process. Its microbiology testing services help customers to identify and measure the potential risks of microbes to a product and ensure that the quality of the products is maintained; and advisory services help customers in navigating the regulatory requirements applicable throughout the product lifecycle. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is based in Broadview Heights, Ohio.
Website: soterahealth.com



Growth: Bad revenue growth rate -6.5%, there is slowdown compared to average historical growth rates 6.1%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is positive, +31.4%. On average the margin is decreasing unsteadily. Gross margin is high, +54.7%. In the last quarter the company did not beat the estimated EPS, -7.1%. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.02 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 89.7% higher than minimum and 3.9% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.1x by EV / Sales multiple , the company can be 53.8% overvalued

Insiders: For the last 3 months insiders sold company shares on $435.6 mln (-9.415% of cap.)

Key Financials (Download financials)

Ticker: SHC
Share price, USD:  (0.0%)18.59
year average price 14.37  


year start price 13.39 2025-02-12

min close price 9.80 2025-04-08

max close price 19.35 2026-01-15

current price 18.59 2026-02-11
Common stocks: 283 260 000

Dividend Yield:  0.0%
FCF Yield LTM: 0.3%
EV / LTM EBITDA: 21.7x
EV / EBITDA annualized: 18.0x
Last revenue growth (y/y):  -6.5%
Last growth of EBITDA (y/y):  -14.0%
Historical revenue growth:  +6.1%
Historical growth of EBITDA:  +6.2%
EV / Sales: 6.8x
Margin (EBITDA LTM / Revenue): 31.4%
Fundamental value created in LTM:
Market Cap ($m): 5 266
Net Debt ($m): 2 208
EV (Enterprise Value): 7 474
Price to Book: 9.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-12seekingalpha.com

Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-11-06globenewswire.com

Sotera Health Announces Secondary Offering of Common Stock

2025-11-04zacks.com

Sotera Health Company (SHC) Q3 Earnings and Revenues Surpass Estimates

2025-10-21globenewswire.com

Sotera Health Announces Third-Quarter 2025 Earnings Release Date

2025-08-27zacks.com

Should You Buy Sotera Health Company (SHC) After Golden Cross?

2025-08-08seekingalpha.com

Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript

2025-08-08globenewswire.com

Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results

2025-07-28globenewswire.com

Sotera Health Announces Second-Quarter 2025 Earnings Release Date

2025-05-02seekingalpha.com

Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript

2025-05-01zacks.com

Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-04 2025-08-08 2024-11-05 2024-08-05 2024-05-02 2023-11-01 2023-08-03 2023-05-03 2022-11-02
acceptedDate 2025-11-04 16:02:08 2025-08-08 16:19:13 2025-02-27 16:02:27 2024-11-05 16:24:40 2024-08-05 16:08:19 2024-05-02 16:40:19 2024-02-27 16:34:11 2023-11-01 16:53:52 2023-08-03 16:11:03 2023-05-03 17:06:32 2023-02-28 16:36:18 2022-11-02 16:41:20 2022-03-01 16:09:24 2021-03-09 16:22:36
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 311M 294M 1 100M 285M 277M 248M 1 049M 263M 255M 221M 1 004M 249M 931M 818M
costOfRevenue 134M 128M 498M 127M 139M 137M 472M 117M 116M 109M 447M 113M 413M 375M
grossProfit 178M 167M 602M 158M 137M 111M 577M 146M 140M 112M 557M 136M 519M 444M
grossProfitRatio 0.57 0.566 0.554 0.497 0.449 0.555 0.547 0.505 0.547
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 63M 69M 243M 62M 52M 52M 237M 54M 60M 62M 246M 57M 198M 179M
otherExpenses 3M 9M 62M 16M 2M -961 000 64M -427 000 2M 16M 63M 16M 64M 59M
operatingExpenses 66M 78M 305M 78M 52M 52M 300M 70M 76M 78M 309M 73M 262M 238M
costAndExpenses 200M 206M 803M 205M 191M 189M 773M 187M 192M 187M 755M 186M 675M 612M
interestIncome 0 0 0 0 0 0 0 30M 31M 0 0 0 0 0
interestExpense 39M 41M 165M 42M 40M 42M 143M 41M 31M 29M 80M 23M 74M 215M
depreciationAndAmortization 26M 36M 164M 43M 40M 41M 158M 16M 16M 17M 146M 38M 151M 144M
ebitda 138M 95M 442M 123M 87M 101M 407M 91M 82M 51M -17M 102M 401M 320M
ebitdaratio 0.445 0.323 0.43 0.454 0.406 0.347 0.32 0.231 0.408
operatingIncome 111M 88M 298M 81M 85M 60M 277M 76M 63M 33M 248M 63M 257M 206M
operatingIncomeRatio 0.357 0.3 0.282 0.308 0.24 0.289 0.248 0.151 0.254
totalOtherIncomeExpensesNet -38M -70M -184M -38M -62M -49M -171M -35M 2M -28M -491M -21M -81M -245M
incomeBeforeTax 73M 19M 114M 43M 15M 11M 106M 470 000 34M 5M -243M 42M 176M -39M
incomeBeforeTaxRatio 0.234 0.064 0.15 0.055 0.044 0.002 0.135 0.024 0.169
incomeTaxExpense 25M 11M 69M 26M 6M 5M 55M 14M 11M 3M -10M 17M 59M -1M
netIncome 48M 8M 44M 17M 9M 6M 51M -14M 24M 3M -234M 25M 117M -39M
netIncomeRatio 0.155 0.027 0.06 0.032 0.025 -0.052 0.092 0.013 0.101
eps 0.17 0.028 0.16 0.06 0.031 0.022 0.18 -0.049 0.08 0.01 -0.83 0.09 0.41 -0.14
epsdiluted 0.17 0.028 0.06 0.031 0.022 -0.049 0.08 0.01 0.09
weightedAverageShsOut 284M 284M 283M 283M 283M 282M 281M 281M 283M 281M 280M 280M 279M 283M
weightedAverageShsOutDil 287M 286M 285M 286M 285M 284M 283M 281M 283M 283M 280M 280M 279M 283M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-02-28 2022-03-01 2021-03-09
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -165M -143M -80M -74M -215M
ebit 279M 249M -163M 250M 176M
nonOperatingIncomeExcludingInterest 19M 28M 411M 7M 30M
netIncomeFromContinuingOperations 44M 51M -234M 117M -37M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 44M 51M -234M 115M -39M
epsDiluted 0.16 0.18 -0.83 0.41 -0.14

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-04 2025-08-08 2024-11-05 2024-08-05 2024-05-02 2023-11-01 2023-08-03 2023-05-03 2022-11-02
acceptedDate 2025-11-04 16:02:08 2025-08-08 16:19:13 2025-02-27 16:02:27 2024-11-05 16:24:40 2024-08-05 16:08:19 2024-05-02 16:40:19 2024-02-27 16:34:11 2023-11-01 16:53:52 2023-08-03 16:11:03 2023-05-03 17:06:32 2023-02-28 16:36:18 2022-11-02 16:41:20 2022-03-01 16:09:24 2021-03-09 16:22:36
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 301M 332M 277M 307M 248M 263M 296M 253M 270M 660M 395M 164M 107M 102M
shortTermInvestments 0 0 0 0 501 000 416 000 0 412 000 422 000 0 0 0 0 0
cashAndShortTermInvestments 301M 332M 277M 307M 248M 263M 296M 253M 270M 660M 395M 164M 107M 102M
netReceivables 195M 180M 166M 177M 161M 141M 176M 118M 117M 109M 156M 164M 134M 131M
inventory 55M 60M 49M 54M 62M 55M 48M 38M 42M 47M 37M 37M 54M 34M
otherCurrentAssets 27M 36M 17M 21M 25M 28M 21M 111M 117M 108M 17M 55M 11M 11M
totalCurrentAssets 578M 608M 526M 564M 498M 487M 557M 520M 547M 924M 645M 421M 346M 315M
propertyPlantEquipmentNet 1 128M 1 112M 1 064M 1 055M 1 019M 1 002M 971M 909M 884M 841M 801M 732M 691M 656M
goodwill 1 099M 1 105M 1 081M 1 105M 1 098M 1 103M 1 111M 1 101M 1 110M 1 103M 1 102M 1 092M 1 120M 1 116M
intangibleAssets 291M 300M 318M 352M 368M 390M 416M 429M 456M 472M 491M 504M 599M 643M
goodwillAndIntangibleAssets 1 390M 1 405M 1 399M 1 457M 1 466M 1 493M 1 528M 1 530M 1 567M 1 575M 1 593M 1 596M 1 719M 1 759M
longTermInvestments 0 0 0 457 000 5M 10M 0 -69M -4M 0 0 0 9M 13M
taxAssets 3M 4M 3M 5M 5M 5M 5M 69M 4M 4M 4M 5M 6M 8M
otherNonCurrentAssets 87M 88M 80M 68M 65M 63M 70M 78M 77M 70M 75M 57M 18M 9M
totalNonCurrentAssets 2 608M 2 609M 2 546M 2 585M 2 560M 2 573M 2 573M 2 517M 2 528M 2 490M 2 473M 2 390M 2 444M 2 446M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 3 186M 3 217M 3 072M 3 149M 3 058M 3 060M 3 130M 3 037M 3 075M 3 414M 3 118M 2 811M 2 790M 2 761M
accountPayables 61M 64M 55M 71M 64M 62M 71M 57M 56M 62M 74M 61M 73M 52M
shortTermDebt 23M 24M 15M 31M 26M 12M 5M 20M 21M 20M 197M 9M 0 0
taxPayables 0 6M 11M 8M 4M 5M 7M 4M 9M 5M 8M 11M 9M 13M
deferredRevenue 14M 12M 15M 11M 13M 13M 13M 13M 14M 15M 12M 5M 9M 6M
otherCurrentLiabilities 144M 141M 41M 75M 61M 66M 37M 111M 110M 503M 43M 65M 37M 39M
totalCurrentLiabilities 242M 246M 191M 196M 170M 152M 231M 201M 200M 600M 792M 140M 161M 141M
longTermDebt 2 254M 2 326M 2 208M 2 335M 2 328M 2 225M 2 224M 2 223M 2 222M 2 222M 1 747M 1 824M 1 744M 1 825M
deferredRevenueNonCurrent 17M 17M 17M 18M 18M 18M 19M 18M 19M 19M 19M 19M 21M 21M
deferredTaxLiabilitiesNonCurrent 54M 48M 70M 64M 54M 60M 64M 69M 68M 63M 68M 152M 135M 122M
otherNonCurrentLiabilities 68M 68M 62M 67M 65M 175M 65M 148M 147M 149M 63M 1 988M 70M 124M
totalNonCurrentLiabilities 2 393M 2 459M 2 476M 2 483M 2 465M 2 478M 2 456M 2 459M 2 456M 2 453M 1 976M 2 064M 2 042M 2 166M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 125M 132M 128M 132M 122M 110M 99M 99M 98M 98M 88M 86M 84M 84M
totalLiabilities 2 636M 2 705M 2 667M 2 679M 2 635M 2 630M 2 687M 2 659M 2 657M 3 053M 2 767M 2 204M 2 203M 2 307M
preferredStock 0 0 0 0 0 765M 0 804M 0 0 0 0 0 0
commonStock 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M
retainedEarnings -567M -615M -610M -622M -639M -648M -654M -693M -679M -703M -706M -386M -472M -589M
accumulatedOtherComprehensiveIncomeLoss -126M -108M -208M -125M -145M -120M -93M -114M -79M -105M -107M -164M -84M -94M
othertotalStockholdersEquity 1 240M 1 232M 1 214M 1 205M 429M 377M 1 174M 1 166M 1 154M
totalStockholdersEquity 550M 511M 405M 470M 423M 429M 444M 377M 418M 361M 350M 607M 586M 452M
totalEquity 550M 511M 405M 470M 423M 429M 444M 377M 418M 361M 350M 607M 586M 455M
totalLiabilitiesAndStockholdersEquity 3 186M 3 217M 3 149M 3 058M 3 060M 3 037M 3 075M 3 414M 2 811M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 2M
totalLiabilitiesAndTotalEquity 3 186M 3 217M 3 072M 3 149M 3 058M 3 060M 3 130M 3 037M 3 075M 3 414M 3 118M 2 811M 2 790M 2 761M
totalInvestments 0 0 0 457 000 5M 10M 0 -69M -4M 0 0 0 9M 13M
totalDebt 2 277M 2 350M 2 351M 2 358M 2 347M 2 346M 2 327M 2 223M 2 222M 2 222M 2 032M 1 833M 1 828M 1 909M
netDebt 1 976M 2 017M 2 073M 2 051M 2 099M 2 083M 2 031M 1 970M 1 951M 1 562M 1 637M 1 669M 1 721M 1 807M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-02-28 2022-03-01 2021-03-09
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 140M 148M 118M 108M 104M
otherReceivables 25M 28M 37M 26M 27M
prepaids 17M 16M 40M 40M 37M
totalPayables 67M 78M 83M 82M 65M
otherPayables 11M 7M 8M 9M 13M
accruedExpenses 45M 83M 447M 23M 20M
capitalLeaseObligationsCurrent 8M 15M 9M 10M 11M
capitalLeaseObligationsNonCurrent 120M 84M 79M 74M 74M
treasuryStock -23M -27M -30M -34M -34M
additionalPaidInCapital 1 244M 1 215M 1 190M 1 173M 1 166M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC SHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-04 2025-08-08 2024-11-05 2024-08-05 2024-05-02 2023-11-01 2023-08-03 2023-05-03 2022-11-02
acceptedDate 2025-11-04 16:02:08 2025-08-08 16:19:13 2025-02-27 16:02:27 2024-11-05 16:24:40 2024-08-05 16:08:19 2024-05-02 16:40:19 2024-02-27 16:34:11 2023-11-01 16:53:52 2023-08-03 16:11:03 2023-05-03 17:06:32 2023-02-28 16:36:18 2022-11-02 16:41:20 2022-03-01 16:09:24 2021-03-09 16:22:36
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 0 8M 44M 17M 9M 6M 51M -14M 24M 3M -234M 25M 117M -37M
depreciationAndAmortization 28M 35M 164M 43M 40M 41M 160M 38M 39M 40M 146M 36M 151M 144M
deferredIncomeTax 0 -9M 9M 10M -5M -3M 3M -145M 2M -2M -74M 7M -4M -23M
stockBasedCompensation 8M 8M 37M 10M 10M 9M 32M 8M 8M 7M 21M 5M 14M 11M
changeInWorkingCapital -14M 35M -43M 17M -15M -41M -403M 4M -414M -16M 409M -1M -13M -12M
accountsReceivables 0 -5M 2M 0 -18M 41M -22M -2M -8M 10M -13M 5M -16M 2M
inventory 0 4M -5M 5M -7M -4M -10M 3M 6M -10M 14M -116 000 -20M 4M
accountsPayables 0 -6M -7M 3M 5M -7M -5M 3M -11M -10M 1M -3M 20M -6M
otherWorkingCapital -14M 42M -33M 9M 5M -70M -366M 541 000 -402M 9M 406M -3M 3M -11M
otherNonCashItems 48M -20M 13M -402 000 104M 59M 8M 150M 4M 2M 9M -3M 16M 39M
netCashProvidedByOperatingActivities 70M 57M 224M 96M 32M 8M -148M 42M -337M 34M 278M 68M 282M 121M
investmentsInPropertyPlantAndEquipment -36M -31M -179M -36M -42M -35M -215M -52M -53M -45M -182M -39M -102M -54M
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 450 000 0 -57M -105M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 3M 0 37 000 0 37 000 37 000 0 32 000 34 000
netCashUsedForInvestingActivites -33M -31M -36M -42M -35M -52M -53M -45M -39M
debtRepayment -75M -4M 0 0 -1M -1M 0 -200M 0
commonStockIssued 0 0 0 0 0 0 0 0 0
commonStockRepurchased 0 -54 000 -4M 0 0 0 -4M 0 0 0 -393 000 0 -1M -34M
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -746 000 -3M -804 000 -29M -9M -2M -710 000 474M -400 000
netCashUsedProvidedByFinancingActivities -76M -7M -804 000 -508 000 -11M -3M -710 000 274M -400 000
effectOfForexChangesOnCash 6M 9M -17M 2M -5M -2M 2M -4M 729 000 1M -4M -4M 44 000 4M
netChangeInCash -33M 28M -23M 61M -15M -39M -95M -18M -390M 264M 289M 24M 4M 39M
cashAtEndOfPeriod 301M 334M 279M 308M 248M 263M 302M 253M 270M 660M 396M 165M 107M 102M
cashAtBeginningOfPeriod 334M 306M 302M 248M 263M 302M 396M 270M 660M 396M 107M 141M 102M 63M
operatingCashFlow 70M 57M 224M 96M 32M 8M -148M 42M -337M 34M 278M 68M 282M 121M
capitalExpenditure -36M -31M -179M -36M -42M -35M -215M -52M -53M -45M -182M -39M -102M -54M
freeCashFlow 33M 26M 45M 59M -10M -26M -363M -10M -390M -11M 96M 29M 179M 67M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-02-28 2022-03-01 2021-03-09
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 74 000 69 000 32 000 -701 000 0
netCashProvidedByInvestingActivities -179M -215M -182M -160M -159M
netDebtIssuance -12M 298M 200M -100M -1 027M
longTermNetDebtIssuance 2 253M 500M 200M -100M -1 027M
shortTermNetDebtIssuance -2 264M -203M 0 0 0
netStockIssuance -4M -4M -393 000 -1M 1 122M
netCommonStockIssuance -4M -4M -393 000 -1M 1 122M
commonStockIssuance 0 0 0 0 1 156M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -34M -27M -2M -16M -21M
netCashProvidedByFinancingActivities -51M 266M 198M -117M 73M
incomeTaxesPaid 66M 50M 75M 52M 24M
interestPaid 180M 174M 76M 59M 211M

Earning call transcript

2025 q3
2025-11-04 ET (fiscal 2025 q3)
2025 q2
2025-08-08 ET (fiscal 2025 q2)
2025 q1
2025-05-02 ET (fiscal 2025 q1)
2024 q4
2025-02-27 ET (fiscal 2024 q4)
2024 q3
2024-11-05 ET (fiscal 2024 q3)
2024 q2
2024-08-05 ET (fiscal 2024 q2)
2024 q1
2024-05-03 ET (fiscal 2024 q1)
2023 q4
2024-03-03 ET (fiscal 2023 q4)
2023 q3
2023-11-04 ET (fiscal 2023 q3)
2023 q2
2023-08-06 ET (fiscal 2023 q2)
2023 q1
2023-05-06 ET (fiscal 2023 q1)
2022 q4
2023-03-03 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-07 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-01-12 12:24 ET
Sotera Health Company published news for 2025 q4
SEC form 8
2026-01-12 12:24 ET
Sotera Health Company published news for 2025 q4
SEC form 8
2025-11-10 16:06 ET
Sotera Health Company published news for 2025 q3
SEC form 8
2025-11-10 16:06 ET
Sotera Health Company published news for 2025 q3
SEC form 8
2025-11-10 16:06 ET
Sotera Health Company published news for 2025 q3
SEC form 10
2025-11-04 16:02 ET
Sotera Health Company reported for 2025 q3
SEC form 8
2025-11-04 07:07 ET
Sotera Health Company published news for 2025 q3
SEC form 8
2025-11-04 07:07 ET
Sotera Health Company reported for 2025 q3
SEC form 8
2025-09-05 20:16 ET
Sotera Health Company published news for 2025 q2
SEC form 8
2025-09-05 20:16 ET
Sotera Health Company published news for 2025 q2
SEC form 8
2025-09-05 20:16 ET
Sotera Health Company published news for 2025 q2
SEC form 10
2025-08-08 20:19 ET
Sotera Health Company reported for 2025 q2
SEC form 8
2025-08-08 11:44 ET
Sotera Health Company published news for 2025 q2
SEC form 8
2025-08-08 11:44 ET
Sotera Health Company reported for 2025 q2
SEC form 10
2025-05-01 20:05 ET
Sotera Health Company published news for 2025 q1
SEC form 8
2025-05-01 11:45 ET
Sotera Health Company published news for 2025 q1
SEC form 8
2025-05-01 11:45 ET
Sotera Health Company reported for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Sotera Health Company published news for 2025 q1
SEC form 10
2025-02-27 16:02 ET
Sotera Health Company reported for 2024 q4
SEC form 8
2025-02-27 07:16 ET
Sotera Health Company published news for 2024 q4
SEC form 8
2025-02-27 07:16 ET
Sotera Health Company reported for 2024 q4
SEC form 10
2025-02-27 00:00 ET
Sotera Health Company reported for 2024 q4
SEC form 8
2025-01-14 00:00 ET
Sotera Health Company published news for 2024 q4
SEC form 8
2025-01-14 00:00 ET
Sotera Health Company published news for 2024 q4
SEC form 10
2024-11-05 16:24 ET
Sotera Health Company reported for 2024 q3
SEC form 8
2024-11-05 07:08 ET
Sotera Health Company published news for 2024 q3
SEC form 8
2024-11-05 07:08 ET
Sotera Health Company reported for 2024 q3
SEC form 10
2024-08-05 16:08 ET
Sotera Health Company published news for 2024 q2
SEC form 8
2024-08-05 07:15 ET
Sotera Health Company published news for 2024 q2
SEC form 8
2024-08-05 07:15 ET
Sotera Health Company reported for 2024 q2
SEC form 10
2024-08-05 00:00 ET
Sotera Health Company published news for 2024 q2
SEC form 10
2024-05-02 16:40 ET
Sotera Health Company published news for 2024 q1
SEC form 8
2024-05-02 11:57 ET
Sotera Health Company published news for 2024 q1
SEC form 8
2024-05-02 11:57 ET
Sotera Health Company published news for 2024 q1
SEC form 8
2024-05-02 07:14 ET
Sotera Health Company published news for 2024 q1
SEC form 8
2024-05-02 07:14 ET
Sotera Health Company reported for 2024 q1
SEC form 10
2024-05-02 00:00 ET
Sotera Health Company published news for 2024 q1
SEC form 10
2024-02-27 16:34 ET
Sotera Health Company published news for 2023 q4
SEC form 8
2024-02-27 07:13 ET
Sotera Health Company published news for 2023 q4
SEC form 8
2024-02-27 07:13 ET
Sotera Health Company reported for 2023 q4
SEC form 10
2024-02-27 00:00 ET
Sotera Health Company published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Sotera Health Company published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Sotera Health Company published news for 2023 q4
SEC form 10
2023-11-01 16:53 ET
Sotera Health Company published news for 2023 q3
SEC form 8
2023-11-01 07:12 ET
Sotera Health Company reported for 2023 q3
SEC form 10
2023-11-01 00:00 ET
Sotera Health Company published news for 2023 q3
SEC form 10
2023-08-03 16:11 ET
Sotera Health Company reported for 2023 q2
SEC form 6
2023-08-03 07:16 ET
Sotera Health Company reported for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Sotera Health Company published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Sotera Health Company published news for 2023 q2
SEC form 6
2023-07-07 07:46 ET
Sotera Health Company published news for 2023 q2
SEC form 6
2023-06-26 17:03 ET
Sotera Health Company published news for 2023 q1
SEC form 6
2023-06-22 17:26 ET
Sotera Health Company published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Sotera Health Company published news for 2023 q1
SEC form 6
2023-03-29 16:23 ET
Sotera Health Company published news for 2022 q4
SEC form 6
2023-03-21 20:43 ET
Sotera Health Company published news for 2022 q4
SEC form 10
2023-02-28 16:36 ET
Sotera Health Company reported for 2022 q4
SEC form 6
2023-02-28 07:16 ET
Sotera Health Company published news for 2022 q4
SEC form 10
2023-02-28 00:00 ET
Sotera Health Company published news for 2022 q4
SEC form 8
2023-02-28 00:00 ET
Sotera Health Company reported for 2022 q4
SEC form 6
2023-02-23 17:27 ET
Sotera Health Company published news for 2022 q4
SEC form 6
2023-02-13 07:20 ET
Sotera Health Company published news for 2022 q4
SEC form 8
2023-02-13 00:00 ET
Sotera Health Company published news for 2022 q4
SEC form 6
2023-01-09 19:05 ET
Sotera Health Company published news for 2022 q4
SEC form 6
2023-01-09 17:24 ET
Sotera Health Company published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Sotera Health Company published news for 2022 q4
SEC form 6
2022-11-09 17:11 ET
Sotera Health Company published news for 2022 q3
SEC form 6
2022-11-08 18:38 ET
Sotera Health Company published news for 2022 q3
SEC form 10
2022-11-02 16:41 ET
Sotera Health Company reported for 2022 q3
SEC form 6
2022-11-02 07:17 ET
Sotera Health Company published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
Sotera Health Company reported for 2022 q3
SEC form 8
2022-11-02 00:00 ET
Sotera Health Company reported for 2022 q3
SEC form 6
2022-10-24 19:21 ET
Sotera Health Company published news for 2022 q3
SEC form 6
2022-10-13 16:21 ET
Sotera Health Company published news for 2022 q3
SEC form 6
2022-10-07 16:24 ET
Sotera Health Company published news for 2022 q3
SEC form 6
2022-09-06 16:49 ET
Sotera Health Company published news for 2022 q2
SEC form 10
2022-08-04 16:08 ET
Sotera Health Company reported for 2022 q2
SEC form 6
2022-08-04 07:12 ET
Sotera Health Company published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Sotera Health Company reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Sotera Health Company reported for 2022 q2
SEC form 6
2022-07-26 17:02 ET
Sotera Health Company published news for 2022 q2
SEC form 6
2022-07-20 17:23 ET
Sotera Health Company published news for 2022 q2
SEC form 6
2022-05-27 16:45 ET
Sotera Health Company published news for 2022 q1
SEC form 6
2022-05-19 17:01 ET
Sotera Health Company published news for 2022 q1
SEC form 10
2022-05-05 17:02 ET
Sotera Health Company reported for 2022 q1
SEC form 6
2022-05-05 07:45 ET
Sotera Health Company published news for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Sotera Health Company reported for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Sotera Health Company reported for 2022 q1
SEC form 6
2022-04-14 08:00 ET
Sotera Health Company published news for 2022 q1
SEC form 10
2022-03-01 16:09 ET
Sotera Health Company published news for 2021 q4
SEC form 6
2022-03-01 07:22 ET
Sotera Health Company published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Sotera Health Company published news for 2021 q4
SEC form 8
2022-03-01 00:00 ET
Sotera Health Company published news for 2021 q4
SEC form 6
2022-01-11 10:15 ET
Sotera Health Company published news for 2021 q4
SEC form 6
2022-01-11 06:52 ET
Sotera Health Company published news for 2021 q4
SEC form 8
2022-01-11 00:00 ET
Sotera Health Company published news for 2021 q4
SEC form 10
2021-11-10 16:11 ET
Sotera Health Company published news for 2021 q3
SEC form 6
2021-11-10 07:37 ET
Sotera Health Company published news for 2021 q3
SEC form 10
2021-11-10 00:00 ET
Sotera Health Company published news for 2021 q3
SEC form 8
2021-11-10 00:00 ET
Sotera Health Company published news for 2021 q3
SEC form 6
2021-11-05 17:43 ET
Sotera Health Company published news for 2021 q3
SEC form 6
2021-08-27 16:38 ET
Sotera Health Company published news for 2021 q2
SEC form 10
2021-08-12 16:07 ET
Sotera Health Company published news for 2021 q2
SEC form 6
2021-08-12 08:51 ET
Sotera Health Company published news for 2021 q2
SEC form 10
2021-08-12 00:00 ET
Sotera Health Company published news for 2021 q2
SEC form 8
2021-08-12 00:00 ET
Sotera Health Company published news for 2021 q2
SEC form 6
2021-05-28 20:24 ET
Sotera Health Company published news for 2021 q1
SEC form 6
2021-05-28 16:53 ET
Sotera Health Company published news for 2021 q1
SEC form 10
2021-05-13 16:05 ET
Sotera Health Company published news for 2021 q1
SEC form 6
2021-05-13 07:34 ET
Sotera Health Company published news for 2021 q1
SEC form 10
2021-05-13 00:00 ET
Sotera Health Company published news for 2021 q1
SEC form 6
2021-04-15 08:00 ET
Sotera Health Company published news for 2021 q1
SEC form 6
2021-03-31 17:14 ET
Sotera Health Company published news for 2020 q4
SEC form 6
2021-03-15 16:08 ET
Sotera Health Company published news for 2020 q4
SEC form 10
2021-03-09 16:22 ET
Sotera Health Company published news for 2020 q4
SEC form 6
2021-03-09 07:44 ET
Sotera Health Company published news for 2020 q4
SEC form 6
2021-01-20 17:29 ET
Sotera Health Company published news for 2020 q4
SEC form 6
2021-01-15 17:09 ET
Sotera Health Company published news for 2020 q4
SEC form 6
2021-01-11 07:08 ET
Sotera Health Company published news for 2020 q4
SEC form 6
2020-12-18 08:49 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:43 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:41 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:37 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:36 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:34 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:33 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:31 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:28 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:27 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:26 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:25 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 21:23 ET
Sotera Health Company published news for 2020 q3
SEC form 6
2020-11-20 20:15 ET
Sotera Health Company published news for 2020 q3